{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:12:00Z","timestamp":1783487520454,"version":"3.55.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.beem.2011.09.004","type":"journal-article","created":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T13:06:36Z","timestamp":1337778396000},"page":"371-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Prevention of Graves\u2019 ophthalmopathy"],"prefix":"10.1016","volume":"26","author":[{"given":"Luigi","family":"Bartalena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2011.09.004_bib1","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMcp0806317","article-title":"Graves\u2019 ophthalmopathy","volume":"360","author":"Bartalena","year":"2009","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2011.09.004_bib2","series-title":"Graves\u2019 orbitopathy. A multidisciplinary approach \u2013 questions and answers","first-page":"211","article-title":"Quality of life","author":"Wiersinga","year":"2010"},{"key":"10.1016\/j.beem.2011.09.004_bib3","first-page":"168","article-title":"Management of Graves\u2019 ophthalmopathy: reality and perspectives","volume":"21","author":"Bartalena","year":"2000","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.beem.2011.09.004_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2265.1995.tb02597.x","article-title":"Natural history of thyroid associated ophthalmopathy","volume":"42","author":"Perros","year":"1995","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2011.09.004_bib5","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves\u2019 ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2011.09.004_bib6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/BF03346614","article-title":"Pathogenesis of Graves\u2019 orbitopathy: a 2010 update","volume":"33","author":"Smith","year":"2010","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.beem.2011.09.004_bib7","first-page":"88","article-title":"Pathophysiology of Graves\u2019 ophthalmopathy: the cycle of a disease","volume":"2993","author":"Bahn","year":"1939","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.09.004_bib8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/105072502761016476","article-title":"Epidemiology and prevention of Graves\u2019 ophthalmopathy","volume":"12","author":"Wiersinga","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2011.09.004_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1530\/eje.0.1460457","article-title":"Graves\u2019 ophthalmopathy: a preventable disease?","volume":"146","author":"Bartalena","year":"2002","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2011.09.004_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/eje.0.1480013","article-title":"Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves\u2019 ophthalmopathy in European and Japanese populations","volume":"143","author":"Bednarczuk","year":"2003","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2011.09.004_bib11","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1210\/jc.2003-030131","article-title":"Intercellular adhesion molecule 1 polymorphisms in Graves\u2019 disease","volume":"88","author":"Kretowski","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.09.004_bib12","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1089\/thy.2008.0098","article-title":"Influence of the TSH receptor gene on susceptibility to Graves\u2019 disease and Graves\u2019 ophthalmopathy","volume":"18","author":"Yin","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2011.09.004_bib13","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1210\/jc.2007-2190","article-title":"Interleukin (IL)-23 receptor is a major susceptibility gene for Graves\u2019 ophthalmopathy: the IL-23\/T-helper 17 axis extends to thyroid autoimmunity","volume":"93","author":"Huber","year":"2008","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.09.004_bib14","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/BF03346682","article-title":"Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves\u2019 disease","volume":"33","author":"Zhu","year":"2010","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.beem.2011.09.004_bib15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1089\/thy.2000.10.791","article-title":"Limited genetic susceptibility to severe Graves\u2019 ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology","volume":"10","author":"Villanueva","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2011.09.004_bib16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1530\/eje.0.1330507","article-title":"Cigarette smoking and the thyroid","volume":"133","author":"Bartalena","year":"1995","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2011.09.004_bib17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/BF03350047","article-title":"More on smoking habits and Graves\u2019 ophthalmopathy","volume":"12","author":"Bartalena","year":"1989","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.beem.2011.09.004_bib18","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1001\/archinte.165.14.1606","article-title":"Smoking and other lifestyle factors and the risk of Graves\u2019 hyperthyroidism","volume":"165","author":"Holm","year":"2005","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.beem.2011.09.004_bib19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jama.1993.03500040045034","article-title":"Smoking and risk of Graves\u2019 disease","volume":"269","author":"Prummel","year":"1993","journal-title":"The Journal of the American Medical Association"},{"key":"10.1016\/j.beem.2011.09.004_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2265.1998.00487.x","article-title":"Current management of thyroid-associated ophthalmopathy in Europe: results of an international survey","volume":"49","author":"Weetman","year":"1998","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2011.09.004_bib21","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-129-8-199810150-00010","article-title":"Cigarette smoking and treatment outcomes in Graves\u2019 ophthalmopathy","volume":"129","author":"Bartalena","year":"1998","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.beem.2011.09.004_bib22","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/bjo.87.6.773","article-title":"Impact of smoking on the response to treatment of thyroid associated ophthalmopathy","volume":"87","author":"Eckstein","year":"2003","journal-title":"British Journal of Ophthalmology"},{"key":"10.1016\/j.beem.2011.09.004_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2265.1996.8220832.x","article-title":"Smoking and endocrine ophthalmopathy: impact of smoking severity and current versus lifetime cigarette consumption","volume":"45","author":"Pfeilschifter","year":"1996","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2011.09.004_bib24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1530\/eje.1.01991","article-title":"Childhood Graves\u2019 ophthalmopathy: results of a European questionnaire study","volume":"153","author":"Krassas","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2011.09.004_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1006\/exer.1997.0353","article-title":"Superoxide radical production stimulates retroocular fibroblast proliferation in Graves\u2019 ophthalmopathy","volume":"65","author":"Burch","year":"1997","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.beem.2011.09.004_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2265.1994.tb02445.x","article-title":"Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: possible role in thyroid-associated ophthalmopathy","volume":"40","author":"Metcalfe","year":"1994","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2011.09.004_bib27","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00002341-199907000-00007","article-title":"The effect of cigarette smoking constituents on the expression of HLA-DR in orbital fibroblasts derived from patients with Graves\u2019 ophthalmopathy","volume":"15","author":"Mack","year":"1999","journal-title":"Ophthalmic Plastic and Reconstructive Surgery"},{"key":"10.1016\/j.beem.2011.09.004_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/jc.2006-1824","article-title":"Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link","volume":"92","author":"Cawood","year":"2007","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.09.004_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/thy.2010.0218","article-title":"Effect of smoking on orbital fat and muscle volume in Graves\u2019 orbitopathy","volume":"21","author":"Regensburg","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2011.09.004_bib30","series-title":"Graves\u2019 orbitopathy. A multidisciplinary approach \u2013 questions and answers","first-page":"248","article-title":"Prevention","author":"Bartalena","year":"2010"},{"issue":"Suppl. 2","key":"10.1016\/j.beem.2011.09.004_bib31","first-page":"185","article-title":"Amelioration of eye changes of Graves\u2019 ophthalmopathy by achieving euthyroidism","volume":"121","author":"Prummel","year":"1989","journal-title":"Acta Endocrinologica (Copenhagen)"},{"key":"10.1016\/j.beem.2011.09.004_bib32","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/archinte.1990.00390170124027","article-title":"Effect of abnormal thyroid function on the severity of Graves\u2019 ophthalmopathy","volume":"150","author":"Prummel","year":"1990","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.beem.2011.09.004_bib33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF03349519","article-title":"Comparison of RA131I treatment protocols for Graves disease","volume":"13","author":"DeGroot","year":"1990","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.beem.2011.09.004_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(89)90945-8","article-title":"Ophthalmopathy and thyroid stimulation","author":"Karlsson","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2011.09.004_bib35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-07-0666","article-title":"Consensus statement of the European Group on Graves\u2019 orbitopathy (EUGOGO) on management of GO","volume":"158","author":"Bartalena","year":"2008","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2011.09.004_bib36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2265.1999.00843.x","article-title":"The course of Graves\u2019 ophthalmopathy is not influenced by near total thyroidectomy: a case-control study","volume":"51","author":"Marcocci","year":"1999","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2011.09.004_bib37","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1210\/jc.2010-2329","article-title":"The dilemma of how to manage Graves\u2019 hyperthyroidism in patients with associated orbitopathy","volume":"96","author":"Bartalena","year":"2011","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.09.004_bib38","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1365-2265.2008.03417.x","article-title":"Relation between Graves\u2019 orbitopathy and radioiodine therapy for Graves\u2019 hyperthyroidism: facts and unsolved questions","volume":"69","author":"Tanda","year":"2008","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2011.09.004_bib39","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","article-title":"Occurrence of ophthalmopathy after treatment for Graves\u2019 hyperthyroidism","volume":"326","author":"Tallstedt","year":"1992","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2011.09.004_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199801083380201","article-title":"Relation between therapy for hyperthyroidism and the course of Graves\u2019 ophthalmopathy","volume":"338","author":"Bartalena","year":"1998","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2011.09.004_bib41","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1210\/jc.2009-0747","article-title":"Thyroid-associated ophthalmopathy after treatment for Graves\u2019 hyperthyroidism with antithyroid drugs or iodine-131","volume":"94","author":"Traisk","year":"2009","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.09.004_bib42","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2265.2008.03279.x","article-title":"Radioiodine therapy (RAI) for Graves\u2019 disease (GD) and the effect on ophthalmopathy: a systematic review","volume":"69","author":"Acharya","year":"2008","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2011.09.004_bib43","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1210\/jc.2005-0507","article-title":"A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves\u2019 ophthalmopathy","volume":"90","author":"Perros","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.09.004_bib44","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1530\/eje.0.1300494","article-title":"Does early administration of thyroxine reduce the development of Graves\u2019 ophthalmopathy after radioiodine treatment?","volume":"130","author":"Tallstedt","year":"1994","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2011.09.004_bib45","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM198911163212001","article-title":"Use of corticosteroids to prevent progression of Graves\u2019 ophthalmopathy after radioiodine therapy for hyperthyroidism","volume":"321","author":"Bartalena","year":"1989","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2011.09.004_bib46","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1210\/jc.2009-2130","article-title":"Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent Graves\u2019 orbitopathy: a retrospective color study","volume":"95","author":"Lai","year":"2010","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.09.004_bib47","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1210\/jc.2009-0506","article-title":"Graves\u2019 orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis","volume":"94","author":"Vannucchi","year":"2009","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.09.004_bib48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in Graves\u2019 disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study","volume":"158","author":"Laurberg","year":"2008","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2011.09.004_bib49","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1210\/jc.2005-1553","article-title":"Glucocorticoids for Graves\u2019 ophthalmopathy: how and when","volume":"90","author":"Bartalena","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.09.004_bib50","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1089\/thy.1999.9.1175","article-title":"The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves\u2019 disease identifies a group at markedly increased risk of ophthalmopathy","volume":"9","author":"Khoo","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2011.09.004_bib51","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1089\/thy.2000.10.809","article-title":"Thyroid-stimulating antibody is related to Graves\u2019 ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves\u2019 disease","volume":"10","author":"Noh","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2011.09.004_bib52","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2265.2004.02033.x","article-title":"Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves\u2019 disease differ and suggest ophthalmopathy is a multiantigenic disease","volume":"60","author":"Goh","year":"2004","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2011.09.004_bib53","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1365-2265.2000.00959.x","article-title":"Association of thyrotrophin receptor antibodies with the clinical features of Graves\u2019 ophthalmopathy","volume":"52","author":"Gerding","year":"2000","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2011.09.004_bib54","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1210\/jc.2005-2813","article-title":"Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2019 ophthalmopathy and help to predict severity and outcome of the disease","volume":"91","author":"Eckstein","year":"2006","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.09.004_bib55","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1089\/thy.2009.0447","article-title":"Effects of thyrotropin abd thyrotropin-receptor-stimulating Graves\u2019 disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondiferentiated orbital fibroblasts of Graves\u2019 ophthalmopathy patients","volume":"20","author":"van Zeijl","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2011.09.004_bib56","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/thy.2010.0123","article-title":"Thyrotropin receptor-stimulating Graves\u2019 disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves\u2019 ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways","volume":"21","author":"van Zeijl","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2011.09.004_bib57","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1056\/NEJMcp0801880","article-title":"Graves\u2019 disease","volume":"358","author":"Brent","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2011.09.004_bib58","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ecl.2009.01.009","article-title":"Treatment of Graves\u2019 hyperthyroidism: evidence-based and emerging modalities","volume":"38","author":"Hegedus","year":"2009","journal-title":"Endocrinology Metabolism Clinics of North America"},{"key":"10.1016\/j.beem.2011.09.004_bib59","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1210\/jcem.74.4.1532179","article-title":"Methimazole and propylthiouracil inhibit the oxygen free radical-induced expression of a 72 kilodalton heat shock protein in Graves\u2019 retroocular fibroblasts","volume":"74","author":"Heufelder","year":"1992","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.09.004_bib60","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/thy.1999.9.297","article-title":"Oxygen free radicals in interleukin-1beta-induced glycosaminoglycan production by retro-ocular fibroblasts from normal subjects and Graves\u2019 ophthalmopathy patients","volume":"9","author":"Lu","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2011.09.004_bib61","first-page":"265","article-title":"Selenium and thyroid autoimmunity","volume":"2","author":"Negro","year":"2008","journal-title":"Biologics"},{"key":"10.1016\/j.beem.2011.09.004_bib62","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2265.2009.03758.x","article-title":"Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis","volume":"73","author":"Nacamulli","year":"2010","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2011.09.004_bib63","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","article-title":"Selenium and the course of mild Graves\u2019 ophthalmopathy","volume":"364","author":"Marcocci","year":"2011","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2011.09.004_bib64","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1530\/eje.0.1440475","article-title":"Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves\u2019 hyperthyroidism treated with antithyroid drugs: a double-blind randomized prospective study","volume":"144","author":"Glinoer","year":"2001","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2011.09.004_bib65","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/thy.1997.7.369","article-title":"Clinical features of patients with Graves\u2019 disease undergoing remission after antithyroid drug treatment","volume":"7","author":"Vitti","year":"1997","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2011.09.004_bib66","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/thy.2010.0181","article-title":"Outcome of very long-term treatment with antithyroid drugs in Graves\u2019 hyperthyroidism associated with Graves\u2019 orbitopathy","volume":"21","author":"Elbers","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2011.09.004_bib67","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1089\/105072503322240004","article-title":"Effects of thyroidectomy alone or followed by radioiodine ablation of thyroid remnants on the outcome of Graves\u2019 ophthalmopathy","volume":"13","author":"Moleti","year":"2003","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2011.09.004_bib68","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1210\/jc.2006-1800","article-title":"Effect of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves\u2019 orbitopathy treated with intravenous glucocorticoids","volume":"92","author":"Menconi","year":"2007","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.09.004_bib69","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/BF03346411","article-title":"Graves\u2019 hyperthyroidism of recent onset and Graves\u2019 orbitopathy: to ablate or not to ablate the thyroid?","volume":"31","author":"Bartalena","year":"2008","journal-title":"Journal of Endocrinological Investigation"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X11001266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X11001266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:43:46Z","timestamp":1761497026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X11001266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1521690X11001266"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2011.09.004","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of Graves\u2019 ophthalmopathy","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2011.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}